The FDA is experiencing a significant loss of experienced staff due to low morale, political interference, and staffing cuts, which threatens its ability to effectively regulate food, drugs, and medical devices under new Commissioner Marty Makary.
Bitcoin's price slipped below $27,000, putting its positive monthly return at risk as a potential federal government shutdown looms. The macro uncertainty and distress in bond markets add to the headwinds for crypto. Ripple's XRP, Solana's SOL, and Tron's TRON outperformed the broader digital asset market. The government shutdown could delay regulatory decisions, including the approval of a spot bitcoin ETF. Despite the challenging macro picture, some analysts have a constructive outlook for BTC and ETH, with short-term price targets between $28,500 and $30,000. Historically, October has been a bullish month for bitcoin, and interest rate dovishness could trigger a breakout. Bitcoin miners are also improving efficiency, but a rally above $30,000 is needed for sustained momentum.